CXCL12 and B-cell chronic lymphocytic leukemia: Compared to healthy donors, the blood levels of CXCL12 or CXCL13 in CLL patients are decreased or increased, respectively [17,19], which may reflect predominant production of these homing chemokines by stromal fibroblasts or myeloid bystander cells (Table 1).